Skip to search formSkip to main contentSkip to account menu

Metastatic Disease Clinical Trial Setting

Known as: METASTATIC 
A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SDTM Treatment Setting TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA).
3503Background: The incidence of SCCA continues to rise annually in the US. 20% of patients (pts) will develop metastatic (met… 
2014
2014
Application of black salve to a thin melanoma that subsequently progressed to metastatic melanoma: a case study
This is a case study of a female patient diagnosed with superficial spreading melanoma who decided to treat the lesion by the… 
2013
2013
The impact of gender on outcomes in patients with metastatic urothelial carcinoma.
2011
2011
Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV).
1009 Background: SOR, a multikinase inhibitor targeting tumor growth and angiogenesis, is indicated for adv renal and… 
2011
2011
Ixabepilone, mitoxantrone, and prednisone for metastatic castration‐resistant prostate cancer after docetaxel‐based therapy
Mitoxantrone plus prednisone and ixabepilone each have modest activity as monotherapy for second‐line chemotherapy in patients… 
2010
2010
Trabectedin for Metastatic Soft Tissue Sarcoma: A Retrospective Single Center Analysis
Soft tissue sarcoma (STS) comprises a large variety of rare malignant tumors. Development of distant metastasis is frequent, even… 
2009
2009
3LBA SOLTI-0701: A double-blind, randomized phase 2b study evaluating the efficacy and safety of sorafenib (SOR) compared to placebo (PL) when administered in combination with capecitabine (CAP) in…
Review
2008
Review
2008
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab
Colorectal cancer continues to be an important public health concern, despite improvements in screening and better systemic… 
Review
2007
Review
2007
Outcome for metastatic (M+) medulloblastoma (MB) treated with carboplatin during craniospinal radiotherapy (CSRT) followed by cyclophosphamide (CPM) and vincristine (VCR): Preliminary results of COG…
2017 Background: The outcome for patients with metastatic medulloblastoma has historically been poor. Carboplatin is both a… 
2005
2005
Hypothyroidism may accompany SU11248 therapy in a subset of patients (pts) with metastatic (met) gastrointestinal stromal tumors (GIST) and is manageable with replacement therapy
3040 Background: SU11248 is an oral, multitargeted kinase inhibitor with antiangiogenic and antitumor activity due to inhibition… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)